Wajeeha Razaq

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: A trial of the ECOG-ACRIN Research Group (E2108).

Seema A. Khan, Fengmin Zhao, Lawrence J. Solin et al. · Journal of Clinical Oncology · 2020 · 123 citations

Medicine, Oncology, Breast Oncology +11

The effect of soluble E-selectin on tumor progression and metastasis

Shin Ae Kang, Céline A. Blache, Sandra Bajaña et al. · BMC Cancer · 2016 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +17

Primary Central Nervous System Mucosa-Associated Lymphoid Tissue Lymphoma: Case Report and Literature Review

Wajeeha Razaq, Anupama Goel, Ali Amin et al. · Clinical Lymphoma & Myeloma · 2009 · 31 citations

Medicine, Oncology, Pathology +13

E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases

Yoshihiro Morita, Mohamed Kamal, Shinae Kang et al. · Molecular Therapy — Nucleic Acids · 2016 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17